Danam Health, Inc. (WGRX)

Danam Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022
Revenue	52.75	34.37	-
Cost of Revenue	-	31.6	-
Gross Profit	4.99	2.77	-
Selling, General & Admin	-	10.12	-
Research & Development	-	0	-
Other Operating Expenses	0	4.75	0.01
Operating Expenses	-	14.87	0.01
Operating Income	-14.95	-12.1	-0.01
Interest Expense / Income	2.47	1.65	-
Other Expense / Income	-0.53	-0.1	-
Pretax Income	-16.9	-13.65	-0.01
Net Income	-16.9	-13.65	-0.01
Free Cash Flow	-0.24	-0.35	0
Gross Margin	9.46%	8.07%	-
Operating Margin	-28.35%	-35.20%	-
Profit Margin	-32.03%	-39.72%	-
Free Cash Flow Margin	-0.46%	-1.02%	-
EBITDA	-14.41	-12	-0.01
EBITDA Margin	-27.32%	-34.91%	-
EBIT	-14.43	-12	-0.01
EBIT Margin	-27.35%	-34.91%	-

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).